-The Hindu Negotiations are at a “critical and sensitive” stage in Geneva, say sources India runs the risk of being excluded from a proposal it co-authored at the World Trade Organisation (WTO) negotiations, in 2020, to “temporarily waive” intellectual property rights (IPR) held, by primarily Western countries, on vaccines, therapeutics and diagnostics for covid-19. Geneva Health Files, a Switzerland-based newsletter portal that tracks developments in intellectual property, first reported on Friday that “a...

-Newsclick.in It appears the stage is being set to scuttle India and South Africa’s IP waiver proposal with regard to Covid vaccines and technology ahead of the 12th WTO Ministerial this month-end. At various global fora, Big Pharma and rich countries have been steadfastly pushing the focus toward supply-side bottlenecks of vaccines and unequal distribution of doses in a bid to steer the discourse away from the more contentious issue of patents...

-TheWire Science * The Indian government has consistently discouraged compulsory licenses on generic drugs.   * One of the big questions the India government has not answered is why it isn’t using pharma PSUs to produce drugs and vaccines. * Not one member of Indian industry is willing to stand up and fight for compulsory licenses, and for patients, says lawyer Murali Neelakantan. India has played a crucial role in supporting South Africa, as a...

-The Hindu The U.S.-supported move will have an effect if countries simultaneously address non-IP bottlenecks among other things The United States has finally relented and declared its support for a temporary waiver of the Trade-Related Aspects of Intellectual Property Rights (TRIPS) agreement for COVID-19 vaccines at the World Trade Organisation (WTO). In October 2020, India and South Africa, at the WTO, proposed waiving Sections 1, 4, 5, and 7 of Part II...

-The Indian Express A waiver on IP protections would mean pharmaceutical firms and vaccine makers across the world can learn how to make these vaccines without fear of lawsuits from companies that originally developed them. In a move that could potentially help increase production of Covid-19 vaccines around the world, the United States on Wednesday announced its support for waiving intellectual property (IP) protections for these vaccines. Subsequently, the European Union (EU) agreed...